Delivery Order SPE2DB22D3011-SPE2DB24FP8NU

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,639.44 firm-fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,360.98 order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract that Amerisourcebergen Drug Corp holds with the Department of Defense to provide pharmaceuticals and medical supplies. No set-aside designation was used for this...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HUMALOG 100 UNIT/ML VIAL 10ML pharmaceutical products. The $1,328.07 contract has a completion date of January 8, 2024. Amerisourcebergen Drug Corp, which provides pharmaceutical products and services to U.S. government agencies, has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,185.92 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562988007 HUMALOG 100 UNIT/ML VIAL 10ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 5, 2023. No set-aside designation was used for this award made against an indefinite delivery contract held by...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,128.24 contract is for the provision of HUMALOG 100 UNIT/ML VIAL 10ML pharmaceutical products, with a completion date of January 3, 2024. Amerisourcebergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has a history of providing pharmaceutical and medical supply products and services to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,277.00 firm-fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a $1,886.31 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML pharmaceutical products. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. The $1,639.44 delivery order was awarded on May 16, 2024 by the Defense Logistics Agency (DLA), a Defense agency, and has an ultimate completion date of May 17, 2024. The contract is a firm fixed price delivery order with no set-aside designation. Amerisourcebergen...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery order of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The $2,220.48 firm fixed-price contract has an ultimate completion date of May 30, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FP8NU
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,956.03 order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML pharmaceuticals. This order is part of Amerisourcebergen's broader indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used for this award, which is scheduled for completion by January 12, 2024. Amerisourcebergen Drug Corp has a history of providing a range of pharmaceutical and medical products to U.S. government agencies, primarily the Department of Defense.

Generated 4/11/24, 10:50 AM